PULMONARY SARCOIDOSIS

Clinical trials for PULMONARY SARCOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new PULMONARY SARCOIDOSIS trials appear

Sign up with your email to follow new studies for PULMONARY SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug aims to cut steroid use in lung sarcoidosis

Disease control Completed

This Phase 3 trial tested a drug called efzofitimod in 268 adults with pulmonary sarcoidosis, a condition that causes lung inflammation. Participants received either the drug or a placebo every 4 weeks for 48 weeks. The main goal was to see if the drug could help people safely re…

Matched conditions: PULMONARY SARCOIDOSIS

Phase: PHASE3 • Sponsor: aTyr Pharma, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

PULMONARY SARCOIDOSIS

Get alerted when new PULMONARY SARCOIDOSIS trials appear

New drug aims to cut steroid use in lung sarcoidosis